SOX2, PIWI proteins, and MALAT1 – plasma-based emerging biomarkers for cancer detection and monitoring
PLOS One · 2025
DOI: 10.1371/journal.pone.0328557 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Ekaterina Kldiashvili und 5 weiteren Autor:innen. Beteiligte Einrichtung: Petre Shotadze Tbilisi Medical Academy, Ketevan Tsamebuli avenue 51/2, Tbilisi, Georgia. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Biomarkers, Tumor, Argonaute Proteins, SOXB1 Transcription Factors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shota Rustaveli National Science Foundation.
Abstract (Originalsprache)
Background
SOX2, PIWI proteins, and MALAT1 are molecular regulators implicated in cancer progression, proliferation, and epithelial-mesenchmal transition (EMT). This study evaluated their expression in plasma samples from patients with colorectal, breast, and prostate cancers, and assessed their correlations with standard immunohistochemical (IHC) markers.
Methods
A total 300 participants were enrolled: 150 patients with histologically confirmed cancers (50 colorectal cancer, 50 breast cancer, and 50 prostate cancer cases) and 150 age- and sex-matched healthy controls. Plasma RNA and protein levels of SOX2, PIWIL1, PIWIL2, and MALAT1 were measured via quantitative real-time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA), respectively. IHC scores (Ki-67, p53, E-cadherin, vimentin, estrogen receptor/progesterone receptor, human epidermal growth factor receptor 2, androgen receptor) were retrieved from clinical records. Receiver-operating characteristic curve (ROC) analysis, multivariable logistic regression (adjusting for age and sex), and Pearson’s correlation coefficients were used to evaluate biomarker diagnostic performance and tumor marker associations.
Results
SOX2, PIWI proteins, and MALAT1 were significantly elevated in cancer patients versus controls ( p < 0.001), with qRT-PCR and ELISA results strongly correlated. All three biomarkers showed strong positive correlations with Ki-67 (r = 0.65–0.72, p < 0.001), and MALAT1 was associated with EMT marker changes (↓E-cadherin, ↑ vimentin; p < 0.001). Adjusted ROC analysis yielded area under the curve (AUC) values of 0.82–0.89 for individual biomarkers, with sensitivity ranging from 72−84% and specificity from 75−87%. SOX2 levels showed significant correlations with Ki-67 and p53 IHC positivity in colorectal and breast cancer tissues (p < 0.01), although the functional significance of p53 staining remains inconclusive .
Conclusion
The differential expression of SOX2, PIWI proteins, and MALAT1 between cancer patients and healthy controls supports their potential utility as plasma-based biomarkers for distinguishing cancer cases from non-cancer cases. These findings support their potential utility as non-invasive biomarkers for distinguishing cancer cases from healthy individuals.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Petre Shotadze Tbilisi Medical Academy, Ketevan Tsamebuli avenue 51/2, Tbilisi, Georgia.
- Institute of Medical and Public Health Research, Ilia State University, Ilia Chavchavadze Avenue 32, Tbilisi, Georgia.
ORCID-Profile: Ekaterina Kldiashvili
Förderung
- Shota Rustaveli National Science Foundation
Zitieren
APA
Kldiashvili, E., Abiatari, I., Kekelia, E., Iordanishvili, S., Metreveli, T., & Dumbadze, E. (2025). SOX2, PIWI proteins, and MALAT1 – plasma-based emerging biomarkers for cancer detection and monitoring. PLOS One. https://doi.org/10.1371/journal.pone.0328557
Vancouver
Kldiashvili E, Abiatari I, Kekelia E, Iordanishvili S, Metreveli T, Dumbadze E. SOX2, PIWI proteins, and MALAT1 – plasma-based emerging biomarkers for cancer detection and monitoring. PLOS One. 2025. doi:10.1371/journal.pone.0328557
BibTeX
@article{Kldiashvili2025,
author = {Kldiashvili, Ekaterina and Abiatari, Ivane and Kekelia, Elene and Iordanishvili, Saba and Metreveli, Tornike and Dumbadze, Eter},
title = {SOX2, PIWI proteins, and MALAT1 – plasma-based emerging biomarkers for cancer detection and monitoring},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0328557}
}
EUVIMED